This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Prozymex A/s. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Igor Stern - Innovator in Dipeptidyl Peptidase I Research
Introduction
Igor Stern is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of biochemistry, particularly in the study of dipeptidyl peptidase I (DPPI) proteins. His work has implications for the design of inhibitors that could be beneficial in various therapeutic applications.
Latest Patents
Igor Stern holds a patent for the invention titled "Dipeptidyl peptidase I crystal structure and its uses." This patent focuses on the structural studies of DPPI proteins, including modified versions and their co-complexes. The invention includes a crystal of DPPI and structural information obtained through X-ray crystallography from both rat and human sources. Furthermore, it outlines methods for utilizing the structural coordinates of DPPI and its mutants to design compounds that can bind to the active site or accessory binding sites, aiming to create improved inhibitors of DPPI or its homologues.
Career Highlights
Igor Stern is associated with Prozymex A/S, where he continues to advance his research in biochemistry. His work has garnered attention for its potential applications in drug design and development, particularly in targeting specific enzymes that play crucial roles in various biological processes.
Collaborations
Igor has collaborated with notable colleagues, including Anders Kadziola and Søren Weis Dahl. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his findings in the scientific community.
Conclusion
Igor Stern's innovative work in the field of dipeptidyl peptidase I research exemplifies the importance of structural studies in biochemistry. His contributions pave the way for future advancements in therapeutic design and enzyme inhibition.